146 related articles for article (PubMed ID: 38430529)
1. Chemical-induced liver cancer: an adverse outcome pathway perspective.
Sanz-Serrano J; Callewaert E; De Boever S; Drees A; Verhoeven A; Vinken M
Expert Opin Drug Saf; 2024 Apr; 23(4):425-438. PubMed ID: 38430529
[TBL] [Abstract][Full Text] [Related]
2. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
3. Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways.
Clerbaux LA; Filipovska J; Nymark P; Chauhan V; Sewald K; Alb M; Sachana M; Beronius A; Amorim MJ; Wittwehr C
ALTEX; 2024; 41(2):233-247. PubMed ID: 37980615
[TBL] [Abstract][Full Text] [Related]
4. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
[TBL] [Abstract][Full Text] [Related]
5. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
[TBL] [Abstract][Full Text] [Related]
6. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.
Halappanavar S; van den Brule S; Nymark P; Gaté L; Seidel C; Valentino S; Zhernovkov V; Høgh Danielsen P; De Vizcaya A; Wolff H; Stöger T; Boyadziev A; Poulsen SS; Sørli JB; Vogel U
Part Fibre Toxicol; 2020 May; 17(1):16. PubMed ID: 32450889
[TBL] [Abstract][Full Text] [Related]
7. A high-level overview of the OECD AOP Development Programme.
Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
[TBL] [Abstract][Full Text] [Related]
8. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
[TBL] [Abstract][Full Text] [Related]
9. Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing.
Arnesdotter E; Gijbels E; Dos Santos Rodrigues B; Vilas-Boas V; Vinken M
Methods Mol Biol; 2022; 2425():521-535. PubMed ID: 35188645
[TBL] [Abstract][Full Text] [Related]
10. Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity.
Vinken M
Methods Mol Biol; 2016; 1425():325-37. PubMed ID: 27311472
[TBL] [Abstract][Full Text] [Related]
11. Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway-Based Approach.
Saarimäki LA; Morikka J; Pavel A; Korpilähde S; Del Giudice G; Federico A; Fratello M; Serra A; Greco D
Adv Sci (Weinh); 2023 Jan; 10(2):e2203984. PubMed ID: 36479815
[TBL] [Abstract][Full Text] [Related]
12. Exploring a mechanism-based approach for the identification of endocrine disruptors using Adverse Outcome Pathways (AOPs) and New Approach Methodologies (NAMs) : A perfluorooctane sulfonic acid case study.
Wiklund L; Pípal M; Weiss J; Beronius A
Toxicology; 2024 May; 504():153794. PubMed ID: 38580097
[TBL] [Abstract][Full Text] [Related]
13. Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathways.
Perkins EJ; Gayen K; Shoemaker JE; Antczak P; Burgoon L; Falciani F; Gutsell S; Hodges G; Kienzler A; Knapen D; McBride M; Willett C; Doyle FJ; Garcia-Reyero N
ALTEX; 2019; 36(1):91-102. PubMed ID: 30332685
[TBL] [Abstract][Full Text] [Related]
14. Derivation, characterisation and analysis of an adverse outcome pathway network for human hepatotoxicity.
Arnesdotter E; Spinu N; Firman J; Ebbrell D; Cronin MTD; Vanhaecke T; Vinken M
Toxicology; 2021 Jul; 459():152856. PubMed ID: 34252478
[TBL] [Abstract][Full Text] [Related]
15. Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment.
Perkins EJ; Ashauer R; Burgoon L; Conolly R; Landesmann B; Mackay C; Murphy CA; Pollesch N; Wheeler JR; Zupanic A; Scholz S
Environ Toxicol Chem; 2019 Sep; 38(9):1850-1865. PubMed ID: 31127958
[TBL] [Abstract][Full Text] [Related]
16. Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations.
Bajard L; Adamovsky O; Audouze K; Baken K; Barouki R; Beltman JB; Beronius A; Bonefeld-Jørgensen EC; Cano-Sancho G; de Baat ML; Di Tillio F; Fernández MF; FitzGerald RE; Gundacker C; Hernández AF; Hilscherova K; Karakitsios S; Kuchovska E; Long M; Luijten M; Majid S; Marx-Stoelting P; Mustieles V; Negi CK; Sarigiannis D; Scholz S; Sovadinova I; Stierum R; Tanabe S; Tollefsen KE; van den Brand AD; Vogs C; Wielsøe M; Wittwehr C; Blaha L
Environ Res; 2023 Jan; 217():114650. PubMed ID: 36309218
[TBL] [Abstract][Full Text] [Related]
17. Adverse outcome pathway development from protein alkylation to liver fibrosis.
Horvat T; Landesmann B; Lostia A; Vinken M; Munn S; Whelan M
Arch Toxicol; 2017 Apr; 91(4):1523-1543. PubMed ID: 27542122
[TBL] [Abstract][Full Text] [Related]
18. sAOP: linking chemical stressors to adverse outcomes pathway networks.
Aguayo-Orozco A; Audouze K; Siggaard T; Barouki R; Brunak S; Taboureau O
Bioinformatics; 2019 Dec; 35(24):5391-5392. PubMed ID: 31329252
[TBL] [Abstract][Full Text] [Related]
19. Putative adverse outcome pathways of the male reproductive toxicity derived from toxicological studies of perfluoroalkyl acids.
Lu T; Mortimer M; Li F; Li Z; Chen L; Li M; Guo LH
Sci Total Environ; 2023 May; 873():162439. PubMed ID: 36848992
[TBL] [Abstract][Full Text] [Related]
20. AOP Report: Inhibition of Chitin Synthase 1 Leading to Increased Mortality in Arthropods.
Schmid S; Song Y; Tollefsen KE
Environ Toxicol Chem; 2021 Aug; 40(8):2112-2120. PubMed ID: 33818824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
